A Comparative Study on The Safety and Efficacy Of Intrathecal 0.5% Hyperbaric Bupivacaine Alone Versus Bupivacaine Along With Adjuvant Dexmedetomidine In Parturient Undergoing Cesarean Section – A Prospective Observational Study
Main Article Content
Abstract
ABSTRACT: AIM: The aim of this study is to assess the efficacy and safety of 0.5% hyperbaric bupivacaine administered alone versus when given along with adjuvant dexmedetomidine in parturients undergoing LSCS.
METHOD: A hundred parturients of ASA grade II & III undergoing LSCS under spinal anaesthesia were randomly assigned into two groups of 50 each. group B received 0.5% hyperbaric bupivacaine (2ml) and group BD received 0.5% hyperbaric bupivacaine (1.9ml) with 10 mcg of dexmedetomidine (0.1ml). The onset and duration of sensory & motor block, intraoperative hemodynamic changes, and duration of analgesia
CONCLUSION: The findings of this study indicate that 10 mcg dexmedetomidine is more beneficial when used in conjunction with 0.5% hyperbaric bupivacaine compared to 0.5% hyperbaric bupivacaine used alone in parturients undergoing C-section under spinal anesthesia.
References
Ghaffari S, Dehghanpisheh L, Tavakkoli F, Mahmoudi H.
The Effect of Spinal versus General Anesthesia on Quality of Life in Women Undergoing Cesarean Delivery on Maternal Request. Cureus. 2018 Dec 11;10(12):e3715.
DOI: 10.7759/cureus.3715
Khare A., Chohala M., Thada B. et al.
A study to compare the efficacy of intrathecal dexmedetomidine versus nalbuphine as an adjuvant to 0.5% hyperbaric bupivacaine for postoperative analgesia in lower abdominal surgeries.
Ain-Shams J Anesthesiol 14, 31 (2022).
https://doi.org/10.1186/s42077-022-00229-y
Rao, V. U., & Prasad, D. S. (2019).
Efficacy of Intrathecal Dexmedetomidine with Bupivacaine versus Fentanyl with Bupivacaine in Spinal Anaesthesia for Elective Caesarean Sections.
Li, Xx., Li, Ym., Lv, Xl. et al.
The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial.
BMC Anesthesiol 20, 190 (2020).
https://doi.org/10.1186/s12871-020-01109-4
Rajan R, Gosavi S N, Dhakate V, Ninave S.
A comparative study of equipotent doses of intrathecal clonidine and dexmedetomidine on characteristics of bupivacaine spinal anesthesia.
J Datta Meghe Inst Med Sci Univ. 2018;13:4-8
Azam, M., Kazmi, I. H., Asad, N., Rehman, A., Amjad, M. W. A., & Jodat, A. (2022).
Effect of Intrathecal Dexmedetomidine as Adjuvant to Bupivacaine in Caesarian Section: A Double Blind Study.
Pakistan Journal of Medical & Health Sciences, 16(05), 34
Sushruth M.R., and Dinesh Govinda Rao.
Effect of adding intrathecal dexmedetomidine as an adjuvant to hyperbaric bupivacaine for elective cesarean section.
Anaesthesia, Pain & Intensive Care (2019): 348-354
Nasr I.A., & Elokda S.A. (2015).
Safety and efficacy of intrathecal adjuvants for cesarean section: bupivacaine, sufentanil, or dexmedetomidine.
Ain-Shams Journal of Anaesthesiology, 8(3), 388
Liu L., Qian J., Shen B., Xiao F., & Shen H. (2019).
Intrathecal dexmedetomidine can decrease the 95% effective dose of bupivacaine in spinal anesthesia for cesarean section: A prospective, double-blinded, randomized study.
Medicine, 98(9)
Bi Y.H., Cui Y.G., Zhang R.Q., Song C.Y., Zhang Y.Z.
A low dose dexmedetomidine as an adjuvant to bupivacaine in caesarean surgery provides better intraoperative somato-visceral sensory block characteristics and postoperative analgesia.
Oncotarget 2017 Jun 29;8(38):63587-63595
DOI: 10.18632/oncotarget.18864
Nasseri K., Ghadami N., Nouri B.
Effects of intrathecal dexmedetomidine on shivering after spinal anesthesia for cesarean section: a double-blind randomized clinical trial.
Drug Des Devel Ther. 2017 Apr 3;11:1107-1113
DOI: 10.2147/DDDT.S131866
Teymourian H., Khorasanizadeh S., Ansar P., Nazari F., Ebrahimi Dehrod M.
Comparison of the Effect of Bupivacaine in Combination with Dexmedetomidine with Bupivacaine Plus Placebo on Neonatal Apgar Score, Bispectral Index, and Sedation Level of Parturient Women.
Anesth Pain Med. 2018 Oct 24;8(5):e81947
DOI: 10.5812/aapm.81947
Xia F., Chang X., Zhang Y. et al.
The effect of intrathecal dexmedetomidine on the dose requirement of hyperbaric bupivacaine in spinal anaesthesia for caesarean section: a prospective, double-blinded, randomized study.
BMC Anesthesiol. 2018;18(1):74
https://doi.org/10.1186/s12871-018-0528-2
Salame C., Bhure A., Badawaik G., Marodkar K., & Parate S. (2014).
Comparative study of efficacy and safety of intrathecal dexmedetomidine versus intrathecal clonidine as an adjuvant with 0.5% hyperbaric bupivacaine total abdominal hysterectomy procedures.
Journal of Evolution of Medical and Dental Sciences, 3(16), 4167-4176
Ali M.S., Aamir R., Zehra T., Fareed Z., & Rabbani M. W. (2022).
Intrathecal Dexmedetomidine: A Study of its Postop Analgesic Effects When Used as an Adjuvant in Elective C-Section Surgery under Spinal Anesthesia.
Pakistan Journal of Medical & Health Sciences, 16(04), 88-90
